The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Accelerate with confidence: Research-based insights to guide CDMO–CRO partnership decisions
Webinar On Demand
In drug development, every delay comes at a cost—lost time, lost opportunity, and lost market share. Rising costs, complex modalities, strict regulations, and supply chain challenges make speed and precision more critical than ever. Yet many programs are slowed by fragmented outsourcing models that introduce inefficiencies, communication gaps, and costly handoffs.
New research from the Tufts Center for the Study of Drug Development points to a more effective path. Using a modeling approach that quantifies both the financial returns and risk-adjusted value of development decisions, researchers found that integrating CDMO, CRO, and clinical supply capabilities with one partner can accelerate timelines, reduce costs, and strengthen control.
This on-demand webinar shares key findings from the study along with real-world examples of how biotech and biopharma companies are applying these strategies to reach milestones faster and with greater strategic control.
Key takeaways include:
- The research methods and modeling techniques behind the Tufts study insights
- Benefits of Thermo Fisher Scientific’s Accelerator™ Drug Development framework
- Case studies and examples illustrating the value of this model in the real world